Joseph O Merrill
Overview
Explore the profile of Joseph O Merrill including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
83
Citations
3256
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bhatraju E, Kennedy D, Gojic A, Iles-Shih M, Merrill J, Samet J, et al.
Addict Sci Clin Pract
. 2025 Jan;
20(1):6.
PMID: 39881397
Background: Initiation of buprenorphine for treatment of opioid use disorder (OUD) in acute care settings improves access and outcomes, however patients who use methamphetamine are less likely to link to...
2.
Price C, Pike K, Treadway A, Palmer J, Merrill J
Mindfulness (N Y)
. 2024 Dec;
15(11):2794-2811.
PMID: 39697819
Objectives: While effective, medication for opioid use disorder (MOUD) treatment outcomes can be limited by co-occurring polysubstance use, mental health, and chronic pain conditions. Interoceptive training may facilitate well-being and...
3.
Ma J, Delaney J, Ruderman S, Nance R, Hahn A, Drumright L, et al.
AIDS Behav
. 2024 Dec;
29(2):480-481.
PMID: 39625560
No abstract available.
4.
Ma J, Delaney J, Ruderman S, Nance R, Hahn A, Drumright L, et al.
AIDS Behav
. 2024 Oct;
29(2):468-479.
PMID: 39465466
Substance use is associated with decreased antiretroviral therapy (ART) adherence among people with HIV (PWH). Adherence plays a significant role in mediating the negative effects of substance use on HIV...
5.
Fortney J, Ratzliff A, Blanchard B, Ferro L, Rouvere J, Chase E, et al.
Contemp Clin Trials
. 2024 Sep;
146():107700.
PMID: 39322115
Background: The gold-standard treatment for opioid use disorder (OUD) is medication for OUD (MOUD). However, less than a quarter of people with OUD initiate MOUD. Expanding the Collaborative Care Model...
6.
Price C, Pike K, Treadway A, Palmer J, Merrill J
Res Sq
. 2024 Jul;
PMID: 39070653
Objective: While effective, medication for opioid use disorder (MOUD) treatment outcomes can be limited by co-occurring polysubstance use, mental health and chronic pain conditions. Interoceptive training may facilitate well-being and...
7.
Rodriguez M, Colgan D, Leyde S, Pike K, Merrill J, Price C
Subst Abuse Treat Prev Policy
. 2024 May;
19(1):25.
PMID: 38702783
Background: There is little study of lifetime trauma exposure among individuals engaged in medication treatment for opioid use disorder (MOUD). A multisite study provided the opportunity to examine the prevalence...
8.
Leyde S, Price C, Colgan D, Pike K, Tsui J, Merrill J
Subst Use Addctn J
. 2024 Feb;
45(3):423-433.
PMID: 38327009
Background: The relationships between opioid use disorder (OUD), chronic pain, and mental health distress are complex and multidirectional. The objective of this exploratory study was to examine the relationship between...
9.
Rodriguez M, Colgan D, Leyde S, Pike K, Merrill J, Price C
Res Sq
. 2024 Jan;
PMID: 38196650
Background: There is little study of lifetime trauma exposure among individuals engaged in medication treatment for opioid use disorder (MOUD). A multisite study provided the opportunity to examine the prevalence...
10.
Nurse Care Management for Opioid Use Disorder Treatment: The PROUD Cluster Randomized Clinical Trial
Wartko P, Bobb J, Boudreau D, Matthews A, McCormack J, Lee A, et al.
JAMA Intern Med
. 2023 Oct;
183(12):1343-1354.
PMID: 37902748
Importance: Few primary care (PC) practices treat patients with medications for opioid use disorder (OUD) despite availability of effective treatments. Objective: To assess whether implementation of the Massachusetts model of...